Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
However, 47% of those with diabetes and 36% with obesity who discontinued these medications restarted them again within a year
Weight Loss Numbers: Breaking Down the Data The primary endpoint of SURMOUNT-5 showed a least-squares mean weight change of negative 20.2% for Tirzepatide versus negative 13.7% for Semaglutide
Tell our Patient Support Team if youre interested in pick-up options for your order
If you experience side effects that you believe may be related to berberine, you can report them through the MHRA Yellow Card Scheme
If your plan doesnt offer coverage, we also provide cost-effective compounded alternatives
This classification means they do not require FDA approval for safety or efficacy before marketing, and manufacturers cannot legally claim to diagnose, treat, cure, or prevent disease
